Altimmune, Inc. (ALT)

4.37 +0.19 (+4.55%) USD  |  NASDAQ  |  Jan 15, 13:15
More

Altimmune Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for ALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EPS GAAP Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
Viking Therapeutics, Inc. Upgrade
CorMedix, Inc. Upgrade
Seres Therapeutics, Inc. Upgrade
Rhythm Pharmaceuticals, Inc. Upgrade
Terns Pharmaceuticals, Inc. Upgrade